This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

ProPhase Labs Inc (PRPH)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 1.64M 572.00K 5.54M 8.23M
Receivables 5.32M 5.41M 3.22M 4.82M
Inventories 2.52M 2.05M 2.69M 1.68M
Other Current Assets 0.00 0.00 0.00 138.00K
Total Current Assets 11.28M 10.72M 13.20M 15.76M
Property, Plant & Equipment, Gross 6.63M 6.22M 5.92M 5.75M
Accumulated Depreciation & Depletion 4.06M 3.86M 3.61M 3.39M
Property, Plant & Equipment, Net 2.56M 2.36M 2.31M 2.36M
Intangibles 3.58M 3.58M 3.58M 3.58M
Other Non-Current Assets 0.00 0.00 0.00 0.00
Total Non-Current Assets 6.14M 5.94M 5.88M 5.94M
Liabilities & Shareholder Equity
Total Assets 17.42M 16.66M 19.08M 21.70M
Accounts Payable 1.01M 1.30M 885.00K 489.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 766.00K 854.00K 485.00K 557.00K
Total Current Liabilities 4.62M 4.91M 7.85M 8.24M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 200.00K 300.00K 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 200.00K 300.00K 0.00 0.00
Total Liabilities 4.82M 5.21M 7.85M 8.24M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 12.60M 11.45M 11.23M 13.46M
Common Par 11.00K 11.00K 10.00K 10.00K
Additional Paid In Capital 43.61M 42.87M 41.55M 40.63M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -5.38M -5.79M -4.70M -1.99M
Treasury Stock -25.64M -25.64M -25.64M -25.19M
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 12.60M 11.45M 11.23M 13.46M
Total Equity 12.60M 11.45M 11.23M 13.46M
Total Liabilities & Stock Equity 17.42M 16.66M 19.08M 21.70M
Total Common Shares Outstanding 16.10M 15.72M 14.83M 14.71M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 5.34M 5.34M 5.34M 4.65M
Basic Weighted Shares Outstanding 15.84M 14.84M 14.82M 14.28M
Diluted Weighted Shares Outstanding 16.28M 14.84M 14.82M 14.28M
Number of Employees 50 50 49 44
Number of Part-Time Employees 0 0 0 1

PRPH ProPhase Labs Inc

Analysts Ratings for PRPH

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell

Brokerage Partners

PRPH Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs